Skip to main content

Search form

  • Log in
  • Membership
  • Advertise
  • eKnowledgeBase
Pharmalive

Pharmalive

  • Business

    Featured Story

    AstraZeneca Picks Location for New R&D Center, Corporate HQ

    AstraZeneca selects location for new global R&D centre and corporate headquarters in Cambridge, UK Move brings AstraZeneca’s small molecule and...

    Read More

    Recent Business Stories

    AMRI Burlington Receives DEA Approval to...
    Royalty Pharma's Bid for Elan Lapses
    Valeant Pharma Plans $1.75B Stock Offering
    Teva to Boost Respiratory Biz With MicroDose...
    Theravance to Proceed With Plan to Split...
    Synergy Pharma Rises As Analyst Starts...

    Quick LInks

    • Podcasts
    • Special Reports
    • Webinars
    • White Papers
    Stay
  • Marketing & Advertising

    Featured Story

    Allergan Survey: 1 in 5 Women Embarrassed to Talk About OAB

    New Survey Reveals One in Five Women Have Information They Keep Secret from their Doctors Even When Medicines Have Already Been Tried, Candid...

    Read More

    Recent Marketing & Advertising Stories

    Professional Golfer Joins With UCB in...
    FDA Investigating 2 Deaths After Zyprexa...
    Report: Historic Slowdown in Healthcare...
    Takeda Diabetes Drugs Launched in U.S.
    PhRMA Statement on Supreme Court Ruling in...
    Unilife Launches New Corporate Website

    Quick Links

    • Podcasts
    • Special Reports
    • Webinars
    • White Papers
    • Marketing Directory
    • Med Ad News Archives
    Stay
  • R&D

    Featured Story

    Lilly Study: Livalo Helps HIV Patients

    New Data Showed Livalo (Pitavastatin) 4 Mg Had Neutral Effects on Fasting Serum Glucose and Hba1c Levels in HIV-Infected Adults With Dyslipidemia...

    Read More

    R&D Recent Stories

    Santarus And Pharming Announce FDA...
    PhRMA Joins with National Minority Quality...
    Daiichi Sankyo Submits a New Drug...
    Celgene's Revlimid Gets MDS Indication
    BMS, AbbVie: PFS in Phase II Elotuzumab Study
    AbbVie Presents Preliminary Results from...

    Quick Links

    • Podcasts
    • Special Reports
    • Webinars
    • White Papers
    • CRO Directory
    • R&D Directions Archives
    Stay
  • Therapeutics

    Featured Story

    FDA Investigating 2 Deaths After Zyprexa Injection

    The patients died 3-4 days after receiving an appropriate dose of the drug

    Read More

    Therapeutics Recent Stories

    Novartis: Jakavi Improved Overall Survival...
    Simponi Study: Majority of Patients...
    Amgen Phase III Ovarian Cancer Drug Meets...
    Celgene Reports 'Meaningful...
    Abbott Initiates Randomized Clinical Trial...
    FDA OKs Revlimid for Mantle Cell Lymphoma

    Quick Links

    • Podcasts
    • Special Reports
    • Webinars
    • White Papers
    Stay
  • Pharmalot

    Featured Story

    ADA's Ratner: We Expect Patient Level Data From All Drugmakers

    Last week, the NIH ran a workshop to examine the safety of several widely used diabetes drugs called GLP-1 inhibitors and whether a definitive link...

    Read More

    Recent Stories

    FDA Investigates Two Deaths In Zyprexa...
    Is It Time To Overhaul The FDA? A Panel With...
    Spinal Tap: Medtronic And The Virtues Of...
    Pharmalot... Pharmalittle... Good Morning
    Supreme Court Rules Drugmakers Can Be Sued...
    READER POLL: Should Diabetes Drugmakers...

    Quick Links

    • Podcasts
    • Special Reports
    • Webinars
    • White Papers
    Stay
  • Resources

    Featured Resource

    IMS-Appature Webinar Series: Enabling the New Marketing Model

    This webinar series brings together experts, thinkers and practitioners from across industry...Read more

    Recent Resources

    IMS-Appature Webinar Series: Enabling the New...
    Connecting with customers: how you can create...
    Early Planning Essential: Best Practices in Late...
    In Pursuit of Patient Adherence
    Analytics in Managed Markets: Negotiate Like a Pro
    Favorable Regulatory Procedures in the Netherlands
    A New Approach to Outsourced Drug Development:...

    Quick Links

    • Podcasts
    • Special Reports
    • Webinars
    • White Papers
    • CRO Directory
    • Marketing Directory
    Stay
  • Directories

    Marketing Communications Directory

    Healthcare Communications Agencies & Marketing Services Directory

    Browse Companies
    Companies A-Z
    List your Organization

    Contract Research Directory

    Qualified Clinical Research Organizations Directory

    Browse Companies
    Companies A-Z
    List your Organization
    Stay
  • Manny Awards
  • Events
  • Jobs

    Latest Job Posting

    Quality Assurance Compliance Specialist

    Technical Resources International Inc. - Bethesda MD (2 months 3 weeks ago)

    Founded in 1979, Technical Resources International, Inc. (TRI) provides a unique range of support services in the areas of Communications, Health and Information Technology to both private industry and government agency clients. TRI is currently seeking a Quality Assurance (QA) Compliance Specialist to join our...

    Read More

    More Jobs

    Director/Senior Director of Human Resources
    Become a Science Teacher
    Research Associate / Sr. Research Associate Protein Chemistry
    Predoctoral Researcher
    Experienced Clinical Project Manager
    Technical Operations Oracle IT Analyst Job
    View all Jobs
    Stay

You are here

Home » Pharmalot » Pharmalot...Pharmalittle...

Pharmalot...Pharmalittle...

Posted Wed, 05/30/2007 - 7:34am by Ed Silverman 0
· Bayer Faces First Lawsuit Over Magnevist Contrast Agent (MarketWatch);

· Japan Sets Unexpectedly Low Price For Roche's Avastin (Yahoo/Reuters);

· Takeda Shares Reach Two-Month High On Actos Sales (Bloomberg News);

· UK's NICE Endorses Pfizer's Champix For Smokers (Yahoo/Reuters);

· Hi-Tech Pharmcal To Pay $2.5M To Medpointe In Settlement (Associated Press).

Tweet
  • Log in or register to post comments

Latest Stories

ADA's Ratner: We Expect Patient Level Data From All Drugmakers
FDA Investigates Two Deaths In Zyprexa Patients
Is It Time To Overhaul The FDA? A Panel With Pharmalot
Spinal Tap: Medtronic And The Virtues Of Releasing Trial Data
Pharmalot... Pharmalittle... Good Morning
Supreme Court Rules Drugmakers Can Be Sued For Pay-To-Delay Deals
READER POLL: Should Diabetes Drugmakers Provide Patient-Level Data?
Citing Side Effects, Japan Pulls Recommendations For HPV Vaccines
Pharmalot... Pharmalittle... Good Morning
New Merck R&D Chief Overhauls Operations & Cuts Are Coming

About Ed Silverman

Ed Silverman is a prize-winning journalist who has covered the pharmaceutical industry for the past 18 years. In addition to editing Pharmalot, he is currently an editor-at-large for Med Ad News.

Read more

© 2012 UBM Canon

Site Information

  • About Us
  • Terms of Use
  • Contact Us
  • Privacy Policy

Follow Us

Find Pharmalive on TwitterFind Pharmalive on FacebookFind Pharmalive on LinkedInPharmalive RSS feed

Site Navigation

  • Home
  • Business
  • Marketing & Advertising
  • R&D
  • Therapeutics
  • Pharmalot
  • Resources
  • Directories
  • Manny Awards
  • Events
  • Jobs
array (
  'excluded' => 
  array (
    'uid' => false,
    'page' => false,
  ),
)